[Form 4] QuidelOrtho Corp Insider Trading Activity

Rhea-AI Filing Summary

Ronald Lee Bowman, Chief Human Resources Officer of QuidelOrtho Corporation (QDEL), reported issuance and vesting activity on 09/15/2025. 2,565 restricted stock units (RSUs) vested and were released into common stock. To satisfy tax withholding obligations, the issuer withheld 918 shares (disposed at an effective price of $28.92 per share), leaving 1,647 shares of common stock directly owned by Bowman after the transaction. The filing also shows 5,132 RSUs remain outstanding and will vest in equal installments on 09/15/2026 and 09/15/2027. The Form 4 was signed by an attorney-in-fact on behalf of Bowman on 09/17/2025.

Positive

• 2,565 RSUs vested, converting to common stock and aligning executive compensation with shareholder interests
• Remaining RSUs (5,132) vest in equal installments, indicating retention incentives tied to future service

Negative

• 918 shares withheld for taxes, reducing the reporting person's immediate net share count following vesting

Insights

Corporate Governance Expert

TL;DR: Standard insider equity vesting and tax withholding; non-material to corporate control or capital structure.

The filing documents routine executive compensation settlement through RSU vesting and share withholding for taxes. The release of 2,565 RSUs increases the reporting person’s direct holdings while the withholding of 918 shares reflects a common mechanism to satisfy tax obligations without cash payment. Remaining unvested RSUs (5,132) indicate continued compensation linkage to future service. There is no indication of stock sales to third parties, loans, pledges, or material changes to ownership percentages disclosed.

Compensation Analyst

TL;DR: Compensation delivery via RSU vesting with share-withholding for taxes; aligns executive pay with shareholder value over time.

The transaction shows typical equity compensation execution: vesting of time-based RSUs and issuer withholding of a portion of shares to cover withholding taxes at an effective per-share price of $28.92. The schedule of remaining vesting in equal installments over the next two years suggests ongoing retention incentive. No cash proceeds to the reporting person were reported, and total outstanding RSUs remain noted for future dilution considerations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bowman Ronald Lee

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		A		2,565(1)	A	$0	2,565	D
Common Stock	09/15/2025		F		918(2)	D	$28.92	1,647	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	09/15/2025		M			2,565	(4)	(4)	Common Stock	2,565	$0	5,132	D

Explanation of Responses:

1. Reflects release of restricted stock units that were previously reported on a Form 4.

2. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

3. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

4. 2,565 shares vested on September 15, 2025; the remaining 5,132 shares shares will vest in equal installments on September 15, 2026 and September 15, 2027.

Remarks:

	/s/ Jennifer Ahn, attorney-in-fact for Ronald Lee Bowman	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did QDEL insider Ronald Lee Bowman report on Form 4?

The Form 4 reports the vesting and release of 2,565 RSUs on 09/15/2025, withholding of 918 shares for taxes, and resulting direct ownership of 1,647 common shares.

How many RSUs remain unvested for Bowman and when will they vest?

The filing states 5,132 RSUs remain and will vest in equal installments on 09/15/2026 and 09/15/2027.

Was there a sale of shares reported by Bowman on this Form 4?

No sale to third parties was reported; the disposition of 918 shares was due to issuer withholding to satisfy tax withholding obligations.

What price was used in the tax-withholding disposition?

The withheld shares are reported with an effective price of $28.92 per share.

Does this Form 4 indicate any change in control or large ownership shift?

No. The filing documents routine compensation vesting and withholding and does not indicate a material change in control or ownership position.